Table 1.

Participants’ characteristics.

	Healthy subjects, N = 10 (M = 6/F = 4)	iNPH patients, N = 10 (M = 5, F = 5)	AD patients, N = 16 (M = 7, F = 9)
Age, years (median, min-max, standard deviation)	75 (68–84) ± 4.7	85 (70–100) ± 9.6	76 (70–82) ± 3.8
Aβ, pg/mL (median, min-max, s.d.)	1082 (453–1515) ± 467	790 (718–1248) ± 267	392 (226–563) ± 96
Tau, pg/mL (median, min-max, s.d.)	103 (49–507) ± 160	157 (75–284) ± 73.4	774 (208–1420) ± 394
p-Tau, pg/mL (median, min-max, s.d.)	26 (7–80) ± 24	26 (15–42) ± 9.2	84 (28–136) ± 31.7
MMSE	//	28 (17–29) ± 3.9	22 (13–27) ± 4.3